ERD

Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Current status and future perspectives in targeted therapy of NPM1-mutated AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Mutant NPM1: Nuclear export and the mechanism of leukemogenesis

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

NPM1-mutated AML with starry sky pattern

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1 -Mutated AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

IDH1-R132 changes vary according to NPM1 and other mutations status in AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Mutant NPM1 Maintains the Leukemic State through HOX Expression

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

The NPM1 mutant defines AML irrespective of blast count

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma.

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AM...

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Periodic Reporting for period 4 - TREAT-NPM1-AML (Improving therapy of NPM1-mutated AML)

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

A Curious Novel Combination of Nucleophosmin ( NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 ...

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Overlapping features of therapy-related and de novoNPM1-mutated AML.

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

NPM1-mutated acute myeloid leukemia: from bench to bedside

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

How I diagnose and treat NPM1-mutated AML

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma

Project: TREAT-NPM1-AML

Updated at: 27-04-2024

Show more information

Project acronym TREAT-NPM1-AML

Resources

Selected filters:

Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML

A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas

Current status and future perspectives in targeted therapy of NPM1-mutated AML

Mutant NPM1: Nuclear export and the mechanism of leukemogenesis

NPM1-mutated AML with starry sky pattern

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates

High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1 -Mutated AML

IDH1-R132 changes vary according to NPM1 and other mutations status in AML

The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein

Mutant NPM1 Maintains the Leukemic State through HOX Expression

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy

The NPM1 mutant defines AML irrespective of blast count

Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML

NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma.

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AM...

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field

Periodic Reporting for period 4 - TREAT-NPM1-AML (Improving therapy of NPM1-mutated AML)

A Curious Novel Combination of Nucleophosmin ( NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 ...

Overlapping features of therapy-related and de novoNPM1-mutated AML.

NPM1-mutated acute myeloid leukemia: from bench to bedside

How I diagnose and treat NPM1-mutated AML

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma